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Abstract
Renal hyperﬁltration is closely linked to cardiometabolic disorders, and it may increase the mortality risk of the general population.
Despite the well-established association between cardiometabolic diseases and sarcopenia, the relationship between renal
hyperﬁltration and sarcopenia has not yet been assessed.
This population-based, cross-sectional study used a nationally representative sample of 13,800 adults from the 2008 to 2011
Korea National Health and Nutrition Examination Survey. Renal hyperﬁltration was deﬁned as the age- and sex-speciﬁc glomerular
ﬁltration rate above the 90th percentile in subjects with normal kidney function (>60mL/min/1.73m2). Appendicular skeletal muscle
(ASM), measured by dual-energy x-ray absorptiometry, was used to assess pre-sarcopenia, which the international consensus
deﬁnes as both ASM per se and ASM that was adjusted for the body mass index and the height.
A total of 1402 (10.2%) participants were classiﬁed as having renal hyperﬁltration. The prevalence of pre-sarcopenia ranged from
11.6% to 33.0%, by deﬁnition. Individuals with pre-sarcopenia had higher risks of renal hyperﬁltration compared to those without pre-
sarcopenia (10.9% vs 17.4%, P< .001; odds ratio [OR]=1.71, 95% conﬁdential interval [CI]=1.48–1.99, P< .001). Multiple logistic
regression analyses also demonstrated this independent association between pre-sarcopenia and renal hyperﬁltration, following
adjustment for confounding factors such as insulin resistance and obesity (OR=1.84, 95% CI=1.57–2.15, P< .001).
In the general population of healthy individuals, pre-sarcopenia might be associated with renal hyperﬁltration independent of
obesity or insulin resistance.
Abbreviations: ASM = appendicular skeletal muscle, BMI = body mass index, CKD = chronic kidney disease, CKD-EPI =
Chronic Kidney Disease Epidemiology collaboration, DXA = dual-energy x-ray absorptiometry, GFR = glomerular ﬁltration rate,
HOMA-IR = homeostasis model assessment of insulin resistance, IFG = impaired fasting glucose, KNHANES = Korea National
Health and Nutrition Examination Survey, OR = odds ratio, RAAS = renin-angiotensin-aldosterone system.
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11. Introduction
The decreased glomerular ﬁltration rate (GFR) is a characteristic
of chronic kidney disease (CKD), and a well-known risk factor
for cardiovascular mortality and metabolic disease.[1,2] In
contrast, renal hyperﬁltration is an abnormally high GFR.[3]
Although renal hyperﬁltration occurs in a healthy population, it
can indicate the preclinical stage of CKD[4] and is associated with
metabolic diseases such as diabetes, hypertension, and
obesity.[5–8] A pooled, international meta-analysis reported a
U-shaped association of GFRwithmortality, which indicates that
hyperﬁltration is linked to the higher mortality rate than CKD.[9]
Loss of muscle mass, or sarcopenia, is closely related to
mortality regardless of age, physical performance, or health
status,[10,11] and the relationship between sarcopenia and
metabolic impairment has been reported by several studies.[11–14]
Although the etiology of sarcopenia has not been clearly
established, factors that contribute to sarcopenia, such as chronic
inﬂammation and insulin resistance, are closely linked to renal
hyperﬁltration.[3,12] Furthermore, sarcopenia increases the risk of
diabetes,[14] which is a determinant factor for renal hyper-
ﬁltration.[3,13] The high mortality rate of sarcopenia might be
associated with renal hyperﬁltration, as sarcopenia is a poor
prognostic marker that is associated with increased mortality
rate, independent of age,[10,11] and the U-shaped mortality curve
[9]
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cardiometabolic components, there is a possibility for sarcopenia
and renal hyperﬁltration to share common pathophysiology.
However, no study has yet investigated the relationship between
sarcopenia and renal hyperﬁltration.
Based on this evidence, we hypothesized that sarcopenia and
renal hyperﬁltration share common pathophysiological mecha-
nisms. The aim of the present study was to investigate the
independent association between sarcopenia and renal hyper-
ﬁltration in the general population, after adjusting for the
potential effects of additional risk factors such as obesity, insulin
resistance, and blood pressure. To the best of our knowledge, this
is the ﬁrst study to explore the relationship between renal
hyperﬁltration and sarcopenia.2. Materials and methods
2.1. Data source and study population
This cross-sectional study extracted data from the 2008 to
2011 Korea National Health and Nutrition Examination
Survey (KNHANES). As previously described in detail,[15]
each KNHANES is composed of independent data sets from the
general population of Korea, similar to the National Health
and Nutrition Examination Survey in the United States. Of the
37,753 participants in the 2008–2011 KNHANES, we initially
selected individuals aged ≥20 years (12,160 men and 15,911
women). Exclusion criteria were missing data for appendicular
skeletal muscle (ASM) mass, determined by dual-energy x-ray
absorptiometry (DXA, QDR 4800A; Hologic Inc., Bedford,
MA), height, body weight, and serum creatinine. We also
excluded individuals with CKD (deﬁned as GFR < 60mL/min/
1.73 m2)[16] or diabetes, both of which are considered major
contributors to renal hyperﬁltration.[3] A total of 13,800Total n=37,753 assessed for eligibility
KNHANES IV-2 (2008, n=9,744)
KNHANES IV-3 (2009, n=10,533)
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Figure 1. Flow diagram of inclusion and exclusion of subjects from the 2008 to 201
V). BMI=body mass index, CKD=chronic kidney disease, DM=diabetes mellitu
2subjects were included in the ﬁnal analysis (Fig. 1). All
participants signed written informed consent. Survey protocol
was approved by the institutional review board of the Korean
Centers for Disease Control and Prevention (2008-04EXP-01-
C, 2009-07CON-03-2C, 2010-02CON-21-C, and 2011-
02CON-06C).
2.2. Deﬁnitions of pre-sarcopenia and renal hyperﬁltration
DXA has been used to assess body muscle distribution as well as
bone density with minimal radiation exposure.[17] In addition
to the assessment of subjects’ muscle distributions throughout
the whole body, ASM was calculated as the sum of lean soft
tissue masses in the arms and legs, excluding all other body parts.
Since the KNHANES data used in the current study evaluated the
muscle mass, and not the muscle quality or strength, we used
the term “pre-sarcopenia” according to the European consensus
guideline.[18] We applied multiple pre-sarcopenia deﬁnitions that
are recommended by international consensus, as follows: ASM/
height[2] (<7.0kg/m2 for men, <5.4kg/m2 for women)[19]; ASM/
body mass index (BMI) (sex-speciﬁc lowest 25th percentile,
<0.909 for men, <0.603 for women); and ASM (<19.75kg for
men, <15.02kg for women).[20] According to the cut points set
by National Institutes of Health (FNIH), which are deﬁned as
ASM/BMI of <0.789 for men and <0.512 for women, the
prevalence of pre-sarcopenia in the study population was 4.1%,
which was not enough for data analysis. Therefore, we
determined other values that are the FNIH suggested as
alternative deﬁnitions of ASM per se,[20] as well as the sex-
speciﬁc, lowest 25th percentile for ASM/BMI. Estimated GFR
was calculated using the Chronic Kidney Disease Epidemiology
collaboration (CKD-EPI) equation,[21] and renal hyperﬁltration
was deﬁned as previously described[22]: GFR > 90th percentile
adjusted for sex and age.Exclude those with age <20 years (n=9,682)
de those with no data of DXA, BMI or serum creatinine
A (n=9,360)
I (n=1,576) 
um creatinine (n=635)
de those with CKD or DM
D (n=521)
 (n=1,385)
1 Korean National Health and Nutrition Examination Surveys (KNHANES IV and
s, DXA=dual-energy x-ray absorptiometry.
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parameters, and lifestyle factors
KNHANES data include a three-part medical history, informa-
tion on dietary intake, and laboratory tests. Medical history,
which included smoking status, alcohol consumption, exercise,
diagnoses, and treatments, was evaluated based on direct
interviews and self-report questionnaires. Dietary intake infor-
mation was collected by well-trained dietary interviewers, using a
24-hour recall method. Blood pressure was manually measured
by well-trained nurses using mercury sphygmomanometers
(Baumanometer; W.A. Baum, Copiague, NY). After an overnight
(at least 8-hour) fast, blood and spot urine samples were
collected, refrigerated, and transported to the central laboratory
(NeoDin Medical Institute, Seoul, South Korea) within 24hours.
Serum lipid proﬁles, as well as levels of glucose, insulin, 25(OH)D
concentration, creatinine, and other biochemical variables (white
blood cell, liver enzymes, etc.) from blood samples were
measured. Proteinuria was characterized as more than 1 positive
dip-stick test.
Regular exercise was referred to engaging in moderate physical
activity (slow-pace swimming, doubles tennis, volleyball, bad-
minton, table tennis, moving light objects, etc.) involved 20-
minute sessions (or longer each time) 3 days a week. Participants
were considered to be heavy drinkers if their alcohol consump-
tion exceeded 140g/week for men and 70g/week for women.[23]
Hypertension was deﬁned as systolic/diastolic blood pressure
≥140/90 mm Hg, or taking anti-hypertensive medications.
Impaired fasting glucose (IFG) was considered if subject’s fasting
blood glucose was 100mg/dL or more. Metabolic syndrome was
deﬁned according to the National Cholesterol Education
Program Adult Treatment Panel III criteria adopted for the
Korean population.[24] Central obesity was characterized using
the following cut-offs adopted for the Korean population: waist
circumference ≥90 and ≥85cm for men and women, respectively
[24]. The homeostasis model assessment of insulin resistance
(HOMA-IR) was calculated as previously described,[25] and
insulin resistance was deﬁned as HOMA-IR > 2.5. Because
vitamin D deﬁciency is known to be associated with sarcopenia,
in regard to both muscle mass and strength,[26,27] we deﬁned
vitamin D deﬁciency as 25(OH)D < 20ng/dL, based on the
clinical practice guideline of the Endocrine Society.[28]2.4. Statistical analyses
We analyzed participant characteristics according to each
individual’s renal hyperﬁltration status, using Student’s t-tests
for continuous variables and chi-square tests for categorical
variables. Data are presented as mean± standard deviation,108 
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Figure 2. Distribution of estimated glomerular ﬁltration rate by sex and age. The 90
year age group in (A) men and (B) women.
3number, or percent. Because fasting insulin, total cholesterol,
triglyceride, high-density lipoprotein cholesterol, and low-density
lipoprotein cholesterol values were not normally distributed,
analyses were performed using log- and back-transformed data.
Multiple logistic regression analysis was used to compute odds
ratios (ORs) to estimate the association between pre-sarcopenia
and renal hyperﬁltration. To evaluate the relationship between
pre-sarcopenia and renal hyperﬁltration, anthropometric char-
acteristics (age, sex, obesity, blood pressure), lifestyle patterns
(exercise, alcohol consumption, cigarette smoking), and bio-
chemical values (fasting plasma glucose, HOMAIR, lipid panels)
were determined as covariates. Statistical analyses were per-
formed using IBM SPSS version 23.0 for Windows (IBM Corp.,
Armonk, NY); P <.05 was considered signiﬁcant.3. Results
The mean age of current study population was 47.2 years, and
less than half (42.5%) of the subjects were men. Although the
mean BMI was 23.4kg/m2, 32.6% of participants were classiﬁed
as having central obesity. The prevalence of pre-sarcopenia
differed for varying deﬁnitions: 11.8% (ASM/BMI), 15.2%
(ASM/height[2]), and 12.7% (ASM). In addition, the ratio of
individuals with pre-sarcopenia was higher in the older age group
(>60 years) than the young (49.7% vs 17.0%, 14.2% vs 10.8%,
27.3% vs 50.8%; all P< .001, ASM/BMI, ASM/height[2], ASM
deﬁnitions, respectively). The prevalence of renal hyperﬁltration
was 10.2% in the overall study population. The mean age- and
sex-speciﬁc GFR and 90th percentile cutoff points are shown in
Fig. 2. The cutoff values for renal hyperﬁltration ranged from
90.5 to 122.5mL/min/1.73m2 for men and from 92.0 to 128.9
mL/min/1.73m2 for women. The prevalence of pre-sarcopenia
gradually increased with age (P for trend< .001, Fig. 3A),
whereas the prevalence of renal hyperﬁltration was similar
among age groups (P for trend= .302, Fig. 3B).
3.1. Characteristics of subjects with renal hyperﬁltration
We compared the baseline characteristics of 1402 individuals
with renal hyperﬁltration and 12,398 participants without renal
hyperﬁltration (Table 1). Participants with renal hyperﬁltration
were relatively younger, with lower BMI, waist circumference
and ASM. Although the fasting plasma glucose level slightly
increased in participants without renal hyperﬁltration, fasting
insulin, HOMA-IR, and the prevalence of IFG were similar to
those of renal hyperﬁltration population (all P>.05). Renal
hyperﬁltration individuals showed higher serum triglycerides and
low 25(OH)D concentration, with slight decreases in the116 
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Han et al. Medicine (2017) 96:26 Medicineprevalence of hypertension and metabolic syndrome. However,
we found more current smokers and heavy alcohol drinkers in
renal hyperﬁltration population. In addition, we observed no
difference in the level of dietary intake between with and without
renal hyperﬁltration groups. The proportions of individuals with
renal hyperﬁltration signiﬁcantly increased in the pre-sarcopenic
group, regardless of pre-sarcopenia deﬁnitions (Fig. 4). The
prevalence of proteinuria was higher in the hyperﬁltration group;
however, there was no statistical difference in proteinuria
prevalence between groups (P= .612) due to the low proteinuria
prevalence (0.6%).
3.2. Multiple logistic regression analysis to evaluate the
relationship between pre-sarcopenia and renal
hyperﬁltration
Several multivariable logistic regression models were applied to
adjust for conventional confounding covariates that affect renal
hyperﬁltration (Table 2). In the basic adjusted model with age
and sex (model 1), pre-sarcopenia signiﬁcantly raised the risk of
renal hyperﬁltration regardless of pre-sarcopenia deﬁnitions (OR
ranges 1.57–1.79, all P< .001). This association remained even
after adjusting factors that could affect renal hyperﬁltration,
including lipids (triglyceride, total cholesterol), plasma glucose,
insulin resistance (HOMA-IR), vitamin D deﬁciency, blood
pressure, central obesity, and lifestyle patterns (exercise, alcohol
drink, and cigarette smoke). As shown in Model 3, pre-
sarcopenia continued to increase the risk of renal hyperﬁltration
(OR ranges 1.62–1.99, all P< .001).44. Discussion and conclusions
The results of this nationally representative, population-based
study showed that, in comparison to individuals with preserved
muscle mass, subjects with pre-sarcopenia had an increased risk
of renal hyperﬁltration independent of glucose impairment,
insulin resistance, and central obesity. Our multivariable logistic
regression analyses clearly showed a signiﬁcant association
between pre-sarcopenia and renal hyperﬁltration, regardless of
pre-sarcopenia deﬁnitions.
Renal hyperﬁltration is a complication of diabetes and a
predictor of complication progression including diabetic ne-
phropathy.[29,30] Furthermore, a recent study concluded that
renal hyperﬁltration is associated with a signiﬁcantly increased
risk of metabolic impairment in the absence of diabetes and,
individuals with renal hyperﬁltration had approximately 60%
increased risk of carotid atherosclerosis and left ventricular
hypertrophy, although none of the study population had diabetes
or prior cardiovascular disease.[31] In addition, other epidemio-
logic studies have reported that renal hyperﬁltrationmay increase
the mortality rates of general populations by 27 to 37%.[9,32]
The mechanisms underlying renal hyperﬁltration and its
adverse outcomes are not clearly understood, but proposed
factors contributing to this condition include inﬂammation,[33]
insulin resistance,[34] and overactivation of the sympathetic
nervous system or renin-angiotensin-aldosterone system
(RAAS).[31] Oxidative stress and inﬂammation could initiate
glomerular structural change, increase glomerular permeability,
and ultimately cause renal hyperﬁltration.[33] Inﬂammation also
Table 1
Characteristics of study participants according to renal hyperﬁltration status.
Parameters Total (N=13,800) Nonrenal hyperﬁltration (N=12,398) Renal hyperﬁltration (N=1402) P
Age, y 47.3±12.4 47.5±15.4 44.8±15.3 <.001
Sex, male, N, % 5,859 (42.5) 5,264 (42.5) 595 (42.4) >.999
Waist circumference, cm 80.3±9.7 80.4±9.7 79.7±9.9 .008
SBP, mm Hg 116.0±16.9 116.1±16.9 115.2±16.5 .065
DBP, mm Hg 74.6±10.6 74.7±10.5 73.9±10.9 .006
ASM, kg 18.8±5.0 18.9±5.0 18.2±4.7 <.001
BMI, kg/m2 23.4±3.3 23.5±3.3 23.1±3.4 <.001
Biochemistry
Fasting glucose, mg/dL 92.8±9.3 92.8±9.3 92.2±9.5 .016
Fasting insulin, mIU/mL 9.7±4.7 9.7±4.7 9.5±4.5 .181
HOMA-IR 2.3±1.3 2.3±1.3 2.2±1.2 .096
Total cholesterol, mg/dL
∗
187.4±35.1 187.8±35.0 183.6±35.4 <.001
HDL cholesterol, mg/dL
∗
52.9±12.6 52.7±12.5 54.4±12.9 <.001
Triglycerides, mg/dL
∗
128.9±105.1 128.7±101.6 130.1±131.4 .008
LDL cholesterol, mg/dL
∗
114.0±31.2 114.5±31.2 109.6±30.5 <.001
WBC, 103/mL 6.0±1.6 5.9±1.6 6.0±1.7 .571
25, OH, D, ng/mL 18.8±6.9 18.8±6.9 18.1±7.0 <.001
Creatinine, mg/dL 0.8±0.2 0.8±0.2 0.6±0.1 <.001
GFR, mL/min/1.73 m2 97.4±15.5 96.5±14.9 113.6±11.2 <.001
AST, IU/L
∗
22.2±13.2 22.1±13.1 22.7±13.8 .528
ALT, IU/L
∗
21.1±18.9 21.1±19.0 21.6±18.0 .484
Proteinuria, N, % 84 (0.6) 74 (0.6) 10 (0.8) .612
Urine speciﬁc gravity 1.018±0.006 1.018±0.006 1.018±0.006 .546
Clinical parameters
HTN, N, % 3260 (23.6) 2974 (24.0) 286 (20.4) .003
IFG, N, % 2740 (19.9) 2484 (20.0) 256 (18.3) .120
MetS, N, % 3381 (24.5) 3081 (24.9) 300 (21.4) .004
Central obesity, N, % 4488 (32.6) 4034 (32.7) 454 (32.5) .908
Lifestyle patterns
Current smoker, N, % 3014 (21.8) 2647 (24.1) 367 (26.2) <.001
Heavy drinker, N, % 2204 (16.0) 1891 (15.3) 313 (22.3) <.001
Regular exercise, N, % 3499 (25.4) 3155 (25.4) 344 (24.5) .457
Dietary intake
Carbohydrate, g/d 315.7±121.9 315.3±122.1 318.9±119.5 .333
Protein, g/d 68.6±37.7 68.5±37.9 69.4±36.1 .422
Fat, g/d 37.0±29.4 36.9±29.4 37.9±29.8 .249
Data for continuous variables were expressed as mean± standard deviation.
∗
Log transformed.
ALT= alanine transaminase, ASM= appendicular skeletal muscle, AST=aspartate aminotransferase, BMI=body mass index, DBP=diastolic blood pressure, GFR=glomerular ﬁltration rate, HDL=high-density
lipoprotein, HOMA-IR=homeostatic model assessment of insulin resistance, HTN=hypertension, IFG= impaired fasting glucose, LDL= low-density lipoprotein, MetS=metabolic syndrome, SBP= systolic blood
pressure, WBC=white blood cell.
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Table 2
Odds ratio and 95% conﬁdential interval of renal hyperﬁltration
according to pre-sarcopenia deﬁnitions.
ASM/BMI ASM/height2 ASM
Crude 1.26 (1.11–1.42) 1.71 (1.48–1.99) 1.48 (1.32–1.66)
Model 1 1.57 (1.38–1.80) 1.73 (1.49–2.01) 1.79 (1.58–2.03)
Model 2 1.57 (1.37–1.79) 1.73 (1.49–2.01) 1.80 (1.58–2.05)
Model 3 1.62 (1.42–1.87) 1.84 (1.57–2.15) 1.99 (1.73–2.28)
Model1: adjusted for age and sex.
Model 2: adjusted for age, sex, regular exercise, heavy drink, and current cigarette smoking.
Model 3: adjusted for age, sex, regular exercise, heavy drink, current smoker, systolic blood pressure,
hypertension, central obesity (deﬁned as waist circumferences), vitamin D deﬁciency (25[OH]D < 20
ng/mL), fasting plasma glucose, insulin resistance (HOMA-IR > 2.5), total cholesterol, and
triglycerides.
Han et al. Medicine (2017) 96:26 Medicineplays a key role in the pathogenesis of insulin resistance,
causing renal hyperﬁltration by altering renal endothelial
function and inducing afferent arteriole relaxation.[36] The
angiotensin-converting enzyme in vascular endothelial cells
inactivates bradykinin, which stimulates nitric oxide release
and counteracts angiotensin II-mediated effects.[37] Angiotensin
II activation increases TGF-b upregulation, thereby accelerates
glomerular and tubulointerstitial injury.[38] Conversely, RAAS
blockade or sympathetic nerve denervation could decrease renal
hyperﬁltration.[39,40] In addition, vitamin D deﬁciency is
associated with RAAS and NF-kB pathway, regulating renal
hyperﬁltration.[41] These factors are also involved in muscle
wasting. Chronic inﬂammation could inﬂuence protein metabo-
lism and contribute to progression of muscle wasting.[33] As
insulin has an anabolic effect that stimulates muscle hypertrophy,
insulin resistance, which is an impairment in insulin signaling,
could induce muscle synthesis.[42,43] In addition, overactivation
of RAAS with TGF-b activation attenuates muscle structure,[44]
whereas vitamin D deﬁciency is positively correlated with muscle
wasting .[45]
The most important limitation of the current study was its
cross-sectional design, which precludes conclusions about
causality. However, we analyzed the risks of pre-sarcopenia
and renal hyperﬁltration and fully adjusted for confounding
factors. Our results indicate that pre-sarcopenia may increase the
risk of renal hyperﬁltration, suggesting that there are shared
underlying mechanisms. Second, in GFR assessment, the CKD-
EPI equation based on serum creatinine was used to determine
renal hyperﬁltration in the current study. Ideally, inulin has been
considered to be the marker for determining GFR. However, it is
difﬁcult to use inulin in primary care; thus, indirect markers using
equations are commonly used. In addition, considering the close
relationship between sarcopenia and albuminuria,[46] and
albuminuria to renal hyperﬁltration,[3] the association between
renal hyperﬁltration and sarcopenia is plausible. Although the
CKD-EPI equation is used to estimate GFR inmany epidemiology
studies, it cannot completely substitute the gold standard method
based on inulin clearance or cystatin C. Third, pre-sarcopenia
was assessed only by dual-energy x-ray absorptiometry, which
reﬂects muscle mass but not skeletal muscle function. We only
determined the muscle mass, and neither the muscle strength nor
physical performance, due to lack of information.
To the best of our knowledge, this is the ﬁrst study to report an
independent association between renal hyperﬁltration and pre-
sarcopenia in the general population. In addition, this is a large
population-based study based on national data, which strength-
ens the statistical reliability of the results. KNHANES represents
the non-institutionalized general population of an Asian country;6therefore, selection bias is minimized. Furthermore, we showed
strong evidence for a close relationship between pre-sarcopenia
and renal hyperﬁltration by adjusting for confounders, and this
association remained regardless of pre-sarcopenia deﬁnitions.
In conclusion, the present study shows that pre-sarcopenia is
associated with renal hyperﬁltration in healthy general popula-
tions. This association was independent of insulin resistance and
central obesity. Prospective longitudinal studies are warranted to
assess causality and identify shared mechanisms.Acknowledgments
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